PCRX
Pacira BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
The post-earnings bull case is that Pacira now has synchronized revenue growth across EXPAREL, ZILRETTA, and iovera, reiterated full-year guidance, and several 2026 data catalysts that could expand the commercial footprint or validate the HCAd platform. Primary filings also show $202.2 million of cash and investments and management states near-term liquidity is adequate [#10-Q-2026-04-30].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
At March 31, 2026, Pacira had about $367.7 million of debt, including 2029 converts and a revolving credit facility, while also spending $50.0 million on buybacks in Q1 [#10-Q-2026-04-30].
Momentum
41
Value
69
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $28.00 · Bull $34.00 · Bear $17.00
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $29.67
Why
Momentum41 · Δ7d -2.7
Value69 · Δ7d +0.0
Sentiment49 · Δ7d -2.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
41
26% active weight
Current posture
7d trendImproving
Δ7d
-2.7
Δ21d
+24.8
Value
69
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
49
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.5
Δ21d
-5.1
Why this grade
Composite grade B. Momentum 41.4 / Value 68.9 / Sentiment 48.9
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$1.01B
Beta
0.25
Shares Out
39.34M
P/E (TTM)
53.8
P/S (TTM)
1.51
P/FCF (TTM)
8.69
Rev YoY
+5.0%
EPS YoY
-31.0%
Gross Margin
+71.5%
Op Margin
+4.1%
Net Debt
$179.78M
Current Ratio
4.73
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology